Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity

Chem Biol Drug Des. 2017 Dec;90(6):1184-1189. doi: 10.1111/cbdd.13038. Epub 2017 Jul 3.

Abstract

A series of benzofuran derivatives was synthesized as analogues of known natural α-glucosidase inhibitors. Their activity was evaluated in enzymatic assay and in rat model of diabetes mellitus. Newly identified inhibitors demonstrate significant potency with IC50 values ranging from 6.50 to 722.2 μm, as well as hypoglycemic activity exceeding the reference drug acarbose. Docking simulations provided insight into structure-activity relationships to direct further development of these novel hypoglycemic agents.

Keywords: benzofurans; diabetes; α-glucosidase.

MeSH terms

  • Animals
  • Benzofurans / chemistry*
  • Benzofurans / metabolism
  • Benzofurans / therapeutic use
  • Binding Sites
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / drug therapy
  • Glucose Tolerance Test
  • Glycoside Hydrolase Inhibitors / chemical synthesis*
  • Glycoside Hydrolase Inhibitors / metabolism
  • Glycoside Hydrolase Inhibitors / therapeutic use
  • Hypoglycemic Agents / chemical synthesis*
  • Hypoglycemic Agents / metabolism
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Molecular Docking Simulation
  • Protein Structure, Tertiary
  • Rats
  • Rats, Wistar
  • Saccharomyces cerevisiae / enzymology
  • Streptozocin / toxicity
  • alpha-Glucosidases / chemistry*
  • alpha-Glucosidases / metabolism

Substances

  • Benzofurans
  • Glycoside Hydrolase Inhibitors
  • Hypoglycemic Agents
  • Streptozocin
  • alpha-Glucosidases